Table 1

Baseline characteristics according to 30 min postload plasma glucose levels during an oral glucose tolerance test

Risk factors30 mPG levels, mmol/LP for trend
Q1 (≤7.5)
(n=526)
Q2 (7.6–8.7)
(n=562)
Q3 (8.8–9.8)
(n=526)
Q4 (≥9.9)
(n=548)
Age, years56.2 (0.4)59.7 (0.4)61.4 (0.4)62.4 (0.4)<0.01
Men, %23.241.348.354.7<0.01
Family history of diabetes, %12.320.217.419.6<0.01
Fasting plasma glucose, mmol/L92.7 (0.3)96.0 (0.3)99.6 (0.3)104.5 (0.3)<0.01
2-hour postload plasma glucose, mmol/L107.9 (1.2)117.1 (1.1)125.9 (1.1)132.8 (1.1)<0.01
Hemoglobin A1c, %5.1 (0.02)5.2 (0.01)5.3 (0.01)5.5 (0.01)<0.01
Pre-diabetes, %10.418.634.754.4<0.01
HOMA-IR1.00 (0.95 to 1.05)1.23 (1.18 to 1.29)1.34 (1.27 to 1.40)1.54 (1.47 to 1.61)<0.01
Insulinogenic index1.40 (1.31 to 1.50)0.74 (0.69 to 0.78)0.58 (0.55 to 0.62)0.41 (0.39 to 0.44)<0.01
Systolic blood pressure, mm Hg124.0 (0.8)127.5 (0.7)129.5 (0.7)133.9 (0.7)<0.01
Diastolic blood pressure, mm Hg76.1 (0.5)78.3 (0.4)79.3 (0.4)81.9 (0.4)<0.01
Use of antihypertensive agents, %20.821.825.729.4<0.01
Serum total cholesterol, mmol/L5.31 (0.04)5.47 (0.04)5.54 (0.04)5.50 (0.04)<0.01
Serum HDL cholesterol, mmol/L1.81 (0.02)1.76 (0.02)1.75 (0.02)1.74 (0.02)0.01
Serum triglycerides, mmol/L1.06 (1.01 to 1.10)1.16 (1.11 to 1.21)1.20 (1.15 to 1.26)1.20 (1.15 to 1.26)<0.01
Use of lipid-modifying medication, %11.311.612.711.70.58
Body mass index, kg/m222.1 (0.1)23.9 (0.1)23.2 (0.1)23.4 (0.1)<0.01
Smoking habits, %21.120.218.122.70.27
Alcohol intake, %54.456.549.448.50.01
Regular exercise, %28.429.231.030.00.41
  • All values are presented as the age- and sex-adjusted mean (SE) or percentages, wherein linear regression was used for continuous variables and the direct method for binary variables. Trend tests were performed using a linear regression for continuous variables and a logistic regression for binary variables in the age- and sex-adjusted model.

  • Serum triglycerides, HOMA-IR, and insulinogenic index are shown as the age- and sex-adjusted geometric means (95%CIs) because their distributions were skewed.

  • HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; 30 mPG, 30 min postload plasma glucose.